The most powerful weight loss medication available — targeting both GLP-1 and GIP receptors. Up to 22.5% body weight reduction in clinical trials.
From assessment to delivery in as few as 4 days. No office visits required.
Answer a 5-minute health questionnaire covering your medical history, current medications, and weight loss goals.
A board-certified U.S. physician evaluates your profile and prescribes tirzepatide if clinically appropriate.
Your prescription is compounded by a licensed 503A pharmacy and cold-shipped express in 3–5 business days.
Dual-action GLP-1/GIP agonist with superior clinical outcomes.
Tirzepatide activates both GLP-1 and GIP receptors for enhanced appetite suppression and metabolic improvement. Clinical trials show up to 22.5% body weight reduction.
Medication, provider consultation, and free express cold-chain shipping included. Compare to Zepbound at $299–$449/mo or Mounjaro at $1,000+/mo without insurance.
Licensed U.S. physicians prescribe if clinically appropriate. Ongoing clinical support included throughout your treatment journey.
Custom-compounded by licensed 503A pharmacies. Temperature-controlled cold-chain shipping to your door in 3–5 business days.
First-in-class dual agonist backed by the SURMOUNT clinical trial program.
Tirzepatide is the first dual GLP-1/GIP receptor agonist — a medication that targets two incretin hormone pathways simultaneously for enhanced metabolic benefits.
No hidden fees. No surprise charges. Everything included.
Compounded tirzepatide contains the same active ingredient as brand-name Mounjaro® and Zepbound®, custom-prepared by a licensed 503A compounding pharmacy for individual patient use when clinically appropriate. Compounded medications are not FDA-approved products.
Tirzepatide activates both GLP-1 and GIP receptors (dual agonist), while semaglutide only activates GLP-1. Clinical trials show tirzepatide produces greater weight loss on average (22.5% vs. 15–17%). However, individual responses vary and your provider can help determine which is right for you.
The SURMOUNT-1 trial showed participants losing up to 22.5% of body weight over 72 weeks — for example, a 250 lb person could lose over 56 lbs. 91% of participants achieved at least 5% weight loss. Individual results vary.
No. Our $258/mo pricing is designed for cash-pay patients. Compare to Zepbound at $299–$449/mo through the manufacturer or Mounjaro at $1,000+/mo without insurance. No prior authorization needed. HSA/FSA accepted.
Similar to semaglutide: nausea, vomiting, diarrhea, and constipation. These typically improve as your body adjusts over the first few weeks. Your provider will guide gradual dose titration to minimize side effects.
Both are highly effective GLP-1 medications. Tirzepatide may produce greater weight loss due to its dual receptor activity but comes at a higher price point ($258 vs. $146/mo). Your provider will review your health profile and goals to recommend the best option.
Complete your online medical intake now. If clinically appropriate, your compounded tirzepatide will be shipped express to your door. $258/mo, all-inclusive.
Begin Assessment →